Quantitative MRI in leukodystrophies

Quantitative MRI in leukodystrophies

Leukodystrophies constitute a large and heterogeneous group of genetic diseases primarily affecting the white matter of the central nervous system. Different disorders target different white matter structural components. Leukodystrophies are most often progressive and fatal. In recent years, novel t...

Full description

Bibliographic Details
Main Authors:	Menno D. Stellingwerff, Petra J.W. Pouwels, Stefan D. Roosendaal, Frederik Barkhof, Marjo S. van der Knaap
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	NeuroImage: Clinical
Subjects:	Quantitative MRI White matter disorders Leukodystrophies Myelin imaging
Online Access:	http://www.sciencedirect.com/science/article/pii/S221315822300116X

Similar Items

Emerging cellular themes in leukodystrophies
by: Joseph C. Nowacki, et al.
Published: (2022-08-01)

Leukodystrophy Imaging: Insights for Diagnostic Dilemmas
by: Rajvi N. Thakkar, et al.
Published: (2024-01-01)

Glial cells in the driver seat of leukodystrophy pathogenesis
by: Luis M. Garcia, et al.
Published: (2020-12-01)

Editorial: Myelin Repair: At the Crossing-Lines of Myelin Biology and Gene Therapy
by: Dominik Fröhlich, et al.
Published: (2022-02-01)

Proton MR Spectroscopy in leukodystrophies
by: Eman Muhammad Abdelsalam, et al.
Published: (2015-12-01)

Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
by: Tomohiro Torii, et al.
Published: (2023-09-01)

The multicellular interplay of microglia in health and disease: lessons from leukodystrophy
by: Woutje M. Berdowski, et al.
Published: (2021-08-01)

Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
by: Xingao Wang, et al.
Published: (2019-12-01)

Leukodystrophies /
by: Raymond, Gerald V., et al.
Published: (2011)

Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates
by: Daphne H. Schoenmakers, et al.
Published: (2023-08-01)

Infantile Metachromatic Leukodystrophy: Case Report
by: Salsabeel Hamad, et al.
Published: (2023-11-01)

Metachromatic leukodystrophy: A case report
by: Gopen Kumar Kundu, et al.
Published: (2016-07-01)

The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics
by: Hiu Chuen Lok, et al.
Published: (2021-03-01)

Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response
by: Matthew D Keefe, et al.
Published: (2020-12-01)

Autosomal Dominant Leukodystrophy: A Disease of the Nuclear Lamina
by: Quasar S. Padiath
Published: (2019-03-01)

Incidences of Terminal Zones of Myelination: An Evaluation of Patients aged 3–30 Years
by: Turgut Seber, et al.
Published: (2023-01-01)

A new mouse model of Canavan leukodystrophy displays hearing impairment due to central nervous system dysmyelination
by: Marina R. Carpinelli, et al.
Published: (2014-06-01)

Recombinant human myelin-associated glycoprotein promoter drives selective AAV-mediated transgene expression in oligodendrocytes
by: Georg evon Jonquieres, et al.
Published: (2016-02-01)

Regional vulnerability of brain white matter in vanishing white matter
by: Jodie H.K. Man, et al.
Published: (2023-06-01)

Delayed post-hypoxic leukoencephalopathy: case report with a review of disease pathophysiology
by: Michael Andrew Meyer
Published: (2013-07-01)

Cortical Pathology in Vanishing White Matter
by: Jodie H. K. Man, et al.
Published: (2022-11-01)

Adult-Onset Metachromatic Leukodystrophy: Two Cases
by: Gaye Eryaşar, et al.
Published: (2011-12-01)

Adult-Onset Metachromatic Leukodystrophy: Two Cases
by: Gaye Eryaşar, et al.
Published: (2011-12-01)

Metachromatic leukodystrophy
by: Prima Cheryl D′souza, et al.
Published: (2013-01-01)

Impairment of Proteasome and Autophagy Underlying the Pathogenesis of Leukodystrophy
by: Dar-Shong Lin, et al.
Published: (2020-05-01)

Hypomyelinating leukodystrophy and movement disorders
by: Jacky Ganguly, et al.
Published: (2023-01-01)

Quantitative MRI reveals widespread, network-specific myelination change during generalized epilepsy progression
by: Gustavo Chau Loo Kung, et al.
Published: (2023-10-01)

A CASE REPORT OF JUVENILE FORM OF METACHROMATIC LEUKODYSTROPHY
by: Muhammad Mohsin Sajjad, et al.
Published: (2021-12-01)

Whole-brain ex-vivo quantitative MRI of the cuprizone mouse model
by: Tobias C. Wood, et al.
Published: (2016-11-01)

The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological, and Genetic Data
by: Majid Alfadhel, et al.
Published: (2021-05-01)

In vivo targeting of a variant causing vanishing white matter using CRISPR/Cas9
by: Anne E.J. Hillen, et al.
Published: (2022-06-01)

Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL) Based on Typical MRI and MRS Findings: A Case Report
by: Mohammad Ali Sahraian, et al.
Published: (2022-03-01)

Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
by: Shanice Beerepoot, et al.
Published: (2019-11-01)

Strong diffusion gradients allow the separation of intra- and extra-axonal gradient-echo signals in the human brain
by: Elena Kleban, et al.
Published: (2020-08-01)

Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions
by: Karthik Muthusamy, et al.
Published: (2023-07-01)

Longitudinal assessment of early-life white matter development with quantitative relaxometry in nonhuman primates
by: Jason F. Moody, et al.
Published: (2022-05-01)

Canavan Disease as a Rare Cause of Leukodystrophy: MRI and MRS Findings
by: Mehmet Haydar Atalar, et al.
Published: (2021-12-01)

Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging
by: Nikkita Khattar, et al.
Published: (2021-10-01)

The leukodystrophy mutation Polr3b R103H causes homozygote mouse embryonic lethality and impairs RNA polymerase III biogenesis
by: Karine Choquet, et al.
Published: (2019-06-01)

Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy
by: Andrea Atzmon, et al.
Published: (2018-09-01)